Hip osteoarthritis. Osteoarthritis of hip
Conditions
Interventions
Intervention 1: Intervention group: A group of 15 people using a new orthosis. In this group, a new orthosis is designed and manufactured and tested on 15 people. Each person wears the new orthosis an
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
55 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having symptoms of hip osteoarthritis. Having pain in the hip joint during daily activities in the past three months Radiographic confirmation of moderate to severe hip osteoarthritis based on Altman criteria Unilateral or bilateral hip osteoarthritis No other musculoskeletal or neurological disorders in the lower limbs or trunk that affect the individual's gait Ability to stand and walk independently for at least 15 minutes Age between 55 and 65 years Having a strength of 3 to 5 in the MMT test for gluteal muscles, hip flexors and extensors, and hip abductors
Exclusion criteria
Exclusion criteria: Use of foot or hip orthoses for the past three months Lower limb length discrepancy History of trauma or surgery in the hip in the past ten years Having any musculoskeletal disease or disorder that directly affects the individual's walking function, such as stroke, Parkinson's disease, diagnosed heart disease, diagnosed respiratory disease, etc. (based on the individual's report, medical record, or specialist's opinion) Passive range of motion in the hip joint in the sagittal plane less than 90 degrees Passive range of motion in the hip joint in the transverse plane less than 15 degrees Maximum hip abduction angle less than 20 degrees Hip flexor contracture greater than 10 degrees
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Joint contact force. Timepoint: Measuring joint contact force in healthy individuals, in individuals with hip osteoarthritis using the Coxathrin orthosis, and the newly designed orthosis. Method of measurement: Using gait analysis devices and specialized software.;Range of motion of joints. Timepoint: Measuring the range of joint motion in healthy and diseased individuals using the Coxatrin orthosis and a newly designed orthosis. Method of measurement: Using gait analysis devices and specialized software.;Muscle-generated force. Timepoint: Measurement of muscle force production in healthy and diseased individuals using the Coxatrin orthosis and a newly designed orthosis. Method of measurement: Using gait analysis devices and specialized software.;Gait performance. Timepoint: Measuring gait performance in healthy and diseased individuals using a Coxatrin orthosis and a newly designed orthosis. Method of measurement: Using gait analysis devices and specialized software. | — |
Secondary
| Measure | Time frame |
|---|---|
| Moment and range of motion of joints, gait parameters. Timepoint: During the intervention. Method of measurement: Motion analysis device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr seyed masud rafiaee
Esfahan University of Medical Sciences
Outcome results
None listed